Drawing for PEPTIDES

USPTO serial 79270032

PEPTIDES

Reviewed by CopyMark Law Group

Reg. 6110114Status 707Renewal
Filing date
Status date
Registration date
Jul 28, 2020
Examiner
PEREZ, STEVEN M
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with PEPTIDES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $425

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kevin R. Erdman

Kevin R. Erdman Brannon Sowers & Cracraft PC101 West Kirkwood AvenueSuite 238Bloomington, IN 47404

Goods and services

ClassDescriptionStatusFirst use
003[ Cosmetic kits comprised of cosmetics; breath freshening sprays; dentifrices; teeth whitening strips impregnated with whitening compositions; breath freshening strips; mouthwashes, not for medical purposes; depilatory preparations; depilatory wax; shaving preparations; shampoos; dry shampoos; hair conditioners; hair lotions; hair spray; lip glosses; lipsticks; pomades for cosmetic purposes; cosmetic pencils; eyebrow pencils; eyebrow cosmetics; cosmetic preparations for eyelashes; make-up; make-up preparations; make-up powder; nail polish; false eyelashes; false nails; make-up removing preparations; tissues impregnated with make-up removing preparations; lacquer-removing preparations; nail varnish removers; toilet water; perfumes; perfumery; antiperspirants ; balms, other than for medical purposes, for use on hair, skin, and lips; creams for leather; cosmetic creams; skin whitening creams; beauty masks; lotions for cosmetic purposes; oils for cosmetic purposes; oils for toiletry purposes; almond milk for cosmetic purposes; cleansing milk for toilet purposes; cosmetic preparations for skin care; cosmetics; phytocosmetic preparations in the nature of cosmetics; nail care preparations; collagen preparations for cosmetic purposes; sunscreen preparations; sun-tanning preparations; tissues impregnated with cosmetic lotions; massage gels, other than for medical purposes; ethereal essences; skin soap; cosmetic preparations for baths; cleansers for intimate personal hygiene purposes, non medicated; bath salts, not for medical purposes; topical herbal extracts for cosmetic purposes; hair dyes; mascara; cosmetic preparations for slimming purposes ]SECTION 71 - CANCELLED—
005[ Pharmaceuticals for the treatment of cardiovascular system, nervous system, immune and neuroendocrine systems, eyes, musculoskeletal system, digestive tract, respiratory system, integumentary system, exocrine system, hematopoietic system, urinary system, reproductive system diseases and disorders, diabetes, allergies, intoxication; medical and veterinary preparations for the treatment of cardiovascular system, nervous system, immune and neuroendocrine systems, eyes, musculoskeletal system, digestive tract, respiratory system, integumentary system, exocrine system, hematopoietic system, urinary system, reproductive system diseases and disorders, diabetes, allergies, intoxication; dietary supplements of trace elements for human and animal use; vitamin preparations; vitamin tablets; ] dietary supplements; dietary supplements for supplementing the lack of vitamins, minerals and micronutrients; dietary supplements for sport nutrition; dietary supplements consisting of amino acids, minerals and trace elements; dietary supplements consisting of vitamins [ ; balms for medical purposes; skin lotions for pharmaceutical purposes; medicated after-shave lotions; pharmaceutical preparations for skin care; medicated serums for treatment of face skin, eyelids, lips; medicated toiletry preparations; medicated shampoos; medicated hair lotions; pharmaceutical preparations for treating dandruff; medicinal hair growth preparations; pomades for medical purposes; bath preparations for medical purposes; therapeutic medical preparations for the bath; medical mud for baths; medicinal mud; bath salts for for medical purposes; salts for mineral water baths for medical purposes; antibacterial soap; disinfectant soap; medicated soap; medicated dentifrices; mouthwashes for medical purposes; medicinal tea; herbal teas for medicinal purposes; dietetic beverages adapted for medical purposes ]ACTIVE—
032[ Isotonic beverages; protein-enriched sports beverages ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 29, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Sep 29, 202671.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Sep 20, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 24, 2026ES71TEAS SECTION 71 RECEIVED—
Jul 28, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Aug 15, 2022CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jan 23, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 18, 2020XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Nov 18, 2020XXCRGENERIC MADRID TRANSACTION CREATED—
Oct 28, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 28, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 12, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 12, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 22, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 27, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 26, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 25, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 25, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 24, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 24, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 24, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Mar 24, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 24, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 24, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 14, 2019RFNTREFUSAL PROCESSED BY IB—
Nov 27, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 27, 2019RFRRREFUSAL PROCESSED BY MPU—
Nov 5, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 4, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 29, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 25, 2019DOCKASSIGNED TO EXAMINER—
Oct 25, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 24, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance